Although the BCR-ABL oncogene is the main driver of CML, cumulative evidence indicates that epigenetic alterations such as aberrant DNA methylation is essential for CML development [1,2,3]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.